HOME > TOP STORIES
TOP STORIES
-
BUSINESS Pfizer Japan Recalling Some Champix Products after Detecting Carcinogen
July 29, 2021
-
ACADEMIA Osteoporosis Society Greatly Alarmed by Vitamin D3 Analog Shortages, Might Take Further Measures
July 29, 2021
-
REGULATORY Forxiga Clears PAFSC, in Line to Become Japan’s 1st CKD Drug in August
July 29, 2021
-
BUSINESS Keytruda Keeps Top Drug Crown in FY2020 despite Double-Digit Dip: Tally
July 28, 2021
-
BUSINESS MSD Urges Expansion of Exclusion Criteria for Spillover Rules as Repeated Cuts Hit Keytruda
July 28, 2021
-
BUSINESS Chugai’s H1 Sales Rise on Growth of Tecentriq, Kadcyla
July 27, 2021
-
BUSINESS Shionogi’s Oral COVID-19 Drug Enters PI in Japan
July 27, 2021
-
BUSINESS Moderna Vaccine’s Minimum Age Lowered to 12 in Japan
July 27, 2021
-
REGULATORY Spread of Regional Formularies Will Depend on “Human Relationships and Consensus-Building”: Professor
July 26, 2021
-
REGULATORY Chuikyo Reps Fret Negative Impact of Tougher Pledge Rule, but MHLW Says It’s Conducive to Stable Supplies
July 26, 2021
-
REGULATORY MHLW to Tighten “Written Pledge” Rule on Generic Listings to Thwart Supply Issues
July 26, 2021
-
REGULATORY Wariness Brewing within MHLW for Medical Fee to Incentivize Hospital Formularies
July 21, 2021
-
REGULATORY Japan to Receive 50 Million More Doses of Moderna Vaccine
July 21, 2021
-
REGULATORY Key MOF Official Wants Budget Neutrality, Cap to Optimize Drug Costs
July 20, 2021
-
REGULATORY Japan Approves COVID-19 Antibody Cocktail, 1st Drug for Mild Cases
July 20, 2021
-
BUSINESS Arcalis Sees Opportunities in mRNA Drugs, Eyes Tens of Billions of Yen in CDMO Sales
July 19, 2021
-
REGULATORY New Pharma Industry Vision to Set Out Roles of Wholesalers: MHLW Director
July 16, 2021
-
REGULATORY Japan to Lower Moderna Vaccine’s Minimum Age to 12
July 16, 2021
-
BUSINESS Guilty Ruling for Ono Employees Now Final and Binding: Onoact Case
July 15, 2021
-
BUSINESS Eisai Taps Continuous Manufacturing for Tazverik, Eyes Its Use for Other Oncology Assets Too
July 14, 2021
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
